Back to Citigroup Inc. Citigroup Inc.

ERNA

1 quarters

Position history for Citigroup Inc.Citigroup Inc.'s holdings in Ernexa Therapeutics Inc.

Yes. Citigroup holds 102 shares of ERNA (Ernexa Therapeutics), worth $326, as of its Q3 2026 13F filing. It opened the position in Q3 2026.

Current Value

$326

Current Shares

102

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
New
102
-
$3260.0%$3.20
17

Other major holders of ERNA: Citadel Advisors LLC, Vanguard Fiduciary Trust Co., Geode Capital Management, LLC, Vanguard Capital Management LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used